France's Ministry of Health has announced proposals to cut pharmacy margins on the sale of reimbursable prescription drugs in 2009 to save an estimated 100.0 million euros ($144.3 million) a year. Details of the project are still at the drawing-board stage but leaked news of the planned reductions has enraged pharmacists.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze